Replies to post #78314 on NanoViricides Inc. (NNVC)

[daBoze]

I think the KABOOM will come in early 2015. JMHO

[Magnus1]

That's no fun!

ICPT was at 70 before yesterday and had a run up prior.

We're at 4.97.

There's a lot of room from here to 70.

[larson1]

Thanks arch. You are knowledgeable about this company - I reread some of your previous post. There is no question you are a solid long and only want the best for this little company. I hope your timeline is wrong but I thank you for your response.

[thefamilyman]

I disagree. I think that tox results are important because a proven safety profile should mean that Flucide can get approved for "expanded access" otherwise known as "compassionate use".

Once the product is curing flu patients who were otherwise on their death bed, I would think that "accelerated approval" should be a given.

Under these circumstances, I would expect see to see significant share price appreciation in 2014, certainly by the end of the 2nd Quarter of 2015.

But I claim no expertise that would give me special insight so this is of course JMHO...

arch433 said...

Human trials/success is the next catalyst.

Tox results will have little impact on sp.

Dead in the water for this year, $7 tops. ICPT type move if/when shows success in humans, 2016 looks like the proper timeline.

If not - $0.

[ZincFinger]

If the tox results are good enough to qualify for a fast track (i.e. no toxicity at a dose 100X the therapeutic dose) (which could still be true with considerably worse results than the current one) the PS will go above and remain above $8 at least IMHO (or 60% or more above whatever it's at at the time.

If you cannot understand the huge significance of low toxicity, especially low enough for a fast track, you are missing a major part of the picture. The COMBINATION of exceptionally low toxicity with the fact that the drug is HOST INDEPENDENT would put the odds of approval into the 80 to 90% or above range.

If the drug is used on a compassionate basis for H7N9 and gets outstanding results that could lead to an ICPT type move (i.e.: multiples in a day) before CTs are completed.